Press release content from Globe Newswire. The AP news staff was not involved in its creation.
Rafarma Secures Joint Venture Agreement with the Pharmaceutical Industry Development Agency of ...
RAFARMA PHARMACEUTICALS INCJanuary 29, 2021 GMT
Nicosia, Cyprus, Jan. 29, 2021 (GLOBE NEWSWIRE) -- Rafarma Pharmaceuticals, Inc. OTC:(RAFA) is pleased to announce its joint venture with the entity known as The Pharmaceutical Industry Development Agency of Uzbekistan which is essentially the Health Department of Uzbekistan. Together the two organizations will produce medicines for use by public health institutions in the Republic of Uzbekistan. This will entail the acquisition of real property (10 hectares in the established Innovative Scientific Production Pharmaceutical Cluster known as “Tashkent Pharma Park”) and construction of a physical plant on the premises. Projected costs are currently at $82,000,000.
Related Keywords
Cyprus , Uzbekistan , Republic Of Uzbekistan , , Health Department Of Uzbekistan , Rafarma Pharmaceuticals Inc , Industry Development Agency Of Uzbekistan , Industry Development Agency , Securities Exchange , Pharmaceutical Industry Development Agency , Health Department , Looking Statements , Securities Exchange Act , சைப்ரஸ் , உஸ்பெகிஸ்தான் , குடியரசு ஆஃப் உஸ்பெகிஸ்தான் , ஆரோக்கியம் துறை ஆஃப் உஸ்பெகிஸ்தான் , பத்திரங்கள் பரிமாற்றம் , ஆரோக்கியம் துறை , பார்க்கிறது அறிக்கைகள் , பத்திரங்கள் பரிமாற்றம் நாடகம் ,
comparemela.com © 2020. All Rights Reserved.